Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng.
Cell & Gene: The Podcast
00:00
Navigating Pricing and Value in Cell and Gene Therapy
The chapter explores the intricate landscape of pricing and value in cell and gene therapy, highlighting the challenges of high costs associated with developing and accessing these innovative treatments. It discusses the complexities faced by provider sites in aligning reimbursement structures with the expenses of advanced therapies and emphasizes the importance of navigating evolving payment models for financial stability.
Transcript
Play full episode
